iCliniq logo

Ask a Doctor Online Now

HomeHealth articlescystic fibrosisWhat is Cystic Fibrosis-Related Diabetes?

Cystic Fibrosis-Related Diabetes - Cause, Symptoms, Pathophysiology, and Management

Verified dataVerified data
0

4 min read

Share

The mucus produced due to cystic fibrosis may lead to inflammation and scarring of the pancreas. Let us learn more about it in this article.

Medically reviewed by

Dr. Nagaraj

Published At July 13, 2023
Reviewed AtJuly 17, 2023

Introduction

There are different types of diabetes. Cystic fibrosis diabetes is one of the types of diabetes occurring among those affected with cystic fibrosis. Type 1 and type 2 diabetes may present among people with cystic fibrosis. Cystic fibrosis diabetes is one of the most common types seen among people with cystic fibrosis.

What Is Cystic Fibrosis?

Cystic fibrosis is a genetic condition in which mucus is produced and builds in organs like the lungs, pancreas, etc. This condition is caused by transferring a defective CFTR gene from both parents. It may be identified before the age of one.

What Is Cystic Fibrosis-Related Diabetes?

The thick and sticky mucus produced in the case of cystic fibrosis may cause inflammation and scarring of the pancreas. Due to this reason, there may be damage to the cells in the pancreas. When cells producing insulin get damaged, they cannot produce enough insulin, which causes high blood sugar levels in the blood. If this continues, it may keep increasing the sugar levels in the blood, resulting in cystic fibrosis diabetes.

Cystic fibrosis diabetes is also called cystic fibrosis-related diabetes ( CFRD). In 2019, it was estimated that 20 % of cystic fibrosis patients suffer from CFRD. CFRD shows characteristics of both type 1 and type 2 diabetes. Individuals affected by CFRD may not show a response to insulin-like other types of diabetes, like type 2 diabetes. This is known as insulin resistance. Insulin resistance is widespread in those on certain medications or pregnant women.

What Is the Cause of Cystic Fibrosis-Related Diabetes?

CFRD is considered a multifactorial condition in which beta cell dysfunction exists in the pancreas and a decrease in the size and number of islet cells in the pancreas.

What Is the Pathophysiology of Cystic Fibrosis-Related Diabetes?

CFRD is caused by the transfer of a defective gene called CFTR. The CFTR gene is expressed in beta cells of the pancreas. Whenever there is a mutation in a gene, it causes dysfunction of beta cells. This causes decreased insulin secretion, causing increased blood glucose levels.

The CFTR mutation also causes damage to the structure of the islet cells of the pancreas. The CFTR protein is located in the ductal cells of the pancreas. When there is a mutation in this protein, it affects normal chloride channel function. Because of this, pancreatic secretion is affected. Pancreatic secretion becomes viscous and contains less water. This leads to the autodigestion of enzymes in the pancreas. This situation leads to cyst formation and slowly progresses to fibrosis of the pancreas. If there is a premature loss of the function of the exocrine gland, there may be an increased risk of getting CFRD.

What Are the Symptoms of Cystic Fibrosis-Related Diabetes?

Many cases of cystic fibrosis diabetes may be identified before the onset of symptoms. Screening for diabetes is very important.

Symptoms of cystic fibrosis diabetes include

  • Occurrence of chest infections frequently.

  • A loss of weight is observed.

  • Experiencing thirst.

  • Frequent urination.

  • Getting tired easily.

In pediatric patients, observation of growth and weight is to be done.

What Are the Complications of Cystic Fibrosis-Related Diabetes?

If not treated early, it may lead to complications like

  • Retinopathy (problems related to eyes).

  • Neuropathy (damage to nerves).

  • Damage to many organs like legs, feet, heart, etc.

How to Diagnose Cystic Fibrosis-Related Diabetes?

To diagnose CFRD, the following tests are to be done.

Screening tests are important and should be done routinely.

  • The 2-hour 75-gram oral glucose tolerance test (or 1.75 g glucose/kg for individuals under 42 kg body weight)

  • Continuous glucose monitoring.

Other tests not recommended are

  • Urine glucose tests.

  • Random measurement of plasma glucose.

  • Test for fructoseamine.

  • Monitoring of hemoglobin A1c levels

Continuous glucose monitoring is being given importance in the diagnosis of CFRD.

How to Treat Cystic Fibrosis-Related Diabetes?

There are different treatments available to treat CFRD.

Diet: A dietician may help plan a diet that should include high-calorie, protein, and fat. The diet given to those with CFRD differs from those given to other types of diabetes. This may be due to the difficulty of maintaining weight in CFRD. This is because of the use of more energy in fighting infections and the functioning of the lungs. If CFTR modulators are given as a treatment, it may increase the weight. In such conditions, the diet should be modified.

Insulin:

Insulin therapy is the common treatment for CFRD. This treatment helps reduce glucose, improve weight gain, and improve the functioning of the lungs. Individuals with CFRD are advised to continue taking the same calories as before treatment with insulin. Treatment of CFRD without fasting hyperglycemia requires only rapid-acting insulin alone for meals. The premeal dosage depends on the ratio of insulin to carbohydrates. Treatment of CFRD with fasting hyperglycemia requires long-acting basal insulin and rapid-acting insulin for meals.

Treatment of CFRD patients who receive overnight continuous gastrostomy tube feeding needs

Intermediate-acting insulin and NPH insulin to handle the continuous carbohydrate load.

CFRD patients may need more insulin during acute illness as they develop insulin resistance. The requirement for insulin may come down after the acute illness resolves.

Based on current guidelines, the fasting glucose requirement is 70-130 mg/dL, and the 3-hour postprandial glucose requirement is below 180 mg/dL.

Physical Activity:

Physical activity provides many benefits, even in the case of CFRD. Regular exercise may benefit.

Differential Diagnosis of Cystic Fibrosis-Related Diabetes

Some characteristics are similar to those of type 1 and type 2 diabetes. But these can be differentiated.

Prognosis of Cystic Fibrosis-Related Diabetes

CFRD is considered a disease that will remain for life but can be treated with insulin therapy. Individuals with cystic fibrosis with CFRD have a higher risk of early death than those with only cystic fibrosis. Regular screening tests and early treatment of CFRD with insulin therapy may reduce the risk of death.

Conclusion

CFRD is a genetic disorder that causes mucus to accumulate in various organs, causing scarring of the pancreas. This leads to high blood sugar levels. Hence, it is important to know about cystic fibrosis, or CFRD, its cause, symptoms, complications, management, and prognosis. Knowing this helps an individual identify the disease and seek help from a healthcare provider early. Early diagnosis helps in getting effective treatment. This, in turn, helps achieve a good quality of life.

Dr. Nagaraj
Dr. Nagaraj

Diabetology

Tags:

cystic fibrosis
Community Banner Mobile
By subscribing, I agree to iCliniq's Terms & Privacy Policy.

Source Article ArrowMost popular articles

Ask your health query to a doctor online

Diabetology

*guaranteed answer within 4 hours

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.

This website uses cookies to ensure you get the best experience on our website. iCliniq privacy policy